UniProt ID | AL9A1_HUMAN | |
---|---|---|
UniProt AC | P49189 | |
Protein Name | 4-trimethylaminobutyraldehyde dehydrogenase | |
Gene Name | ALDH9A1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 494 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Converts gamma-trimethylaminobutyraldehyde into gamma-butyrobetaine. Catalyzes the irreversible oxidation of a broad range of aldehydes to the corresponding acids in an NAD-dependent reaction.. | |
Protein Sequence | MSTGTFVVSQPLNYRGGARVEPADASGTEKAFEPATGRVIATFTCSGEKEVNLAVQNAKAAFKIWSQKSGMERCRILLEAARIIREREDEIATMECINNGKSIFEARLDIDISWQCLEYYAGLAASMAGEHIQLPGGSFGYTRREPLGVCVGIGAWNYPFQIASWKSAPALACGNAMVFKPSPFTPVSALLLAEIYSEAGVPPGLFNVVQGGAATGQFLCQHPDVAKVSFTGSVPTGMKIMEMSAKGIKPVTLELGGKSPLIIFSDCDMNNAVKGALMANFLTQGQVCCNGTRVFVQKEILDKFTEEVVKQTQRIKIGDPLLEDTRMGPLINRPHLERVLGFVKVAKEQGAKVLCGGDIYVPEDPKLKDGYYMRPCVLTNCRDDMTCVKEEIFGPVMSILSFDTEAEVLERANDTTFGLAAGVFTRDIQRAHRVVAELQAGTCFINNYNVSPVELPFGGYKKSGFGRENGRVTIEYYSQLKTVCVEMGDVESAF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSTGTFVVS ------CCCCEEEEC | 35.23 | 22223895 | |
2 | Phosphorylation | ------MSTGTFVVS ------CCCCEEEEC | 35.23 | 20068231 | |
3 | Phosphorylation | -----MSTGTFVVSQ -----CCCCEEEECC | 38.65 | 20068231 | |
5 | Phosphorylation | ---MSTGTFVVSQPL ---CCCCEEEECCCC | 17.22 | 20068231 | |
9 | Phosphorylation | STGTFVVSQPLNYRG CCCEEEECCCCCCCC | 22.30 | 20068231 | |
11 | Phosphorylation | GTFVVSQPLNYRGGA CEEEECCCCCCCCCC | 18.31 | 18669648 | |
14 | Phosphorylation | VVSQPLNYRGGARVE EECCCCCCCCCCEEC | 20.51 | 24043423 | |
15 | Methylation | VSQPLNYRGGARVEP ECCCCCCCCCCEECC | 35.68 | - | |
20 | Phosphorylation | NYRGGARVEPADASG CCCCCCEECCCCCCC | 11.65 | 27251275 | |
26 | Acetylation | RVEPADASGTEKAFE EECCCCCCCCCCCCC | 46.96 | 20068231 | |
26 | Phosphorylation | RVEPADASGTEKAFE EECCCCCCCCCCCCC | 46.96 | 20068231 | |
28 | Phosphorylation | EPADASGTEKAFEPA CCCCCCCCCCCCCCC | 31.64 | 26437602 | |
30 | Acetylation | ADASGTEKAFEPATG CCCCCCCCCCCCCCC | 59.21 | 23954790 | |
30 | Malonylation | ADASGTEKAFEPATG CCCCCCCCCCCCCCC | 59.21 | 26320211 | |
30 | Succinylation | ADASGTEKAFEPATG CCCCCCCCCCCCCCC | 59.21 | - | |
30 | Succinylation | ADASGTEKAFEPATG CCCCCCCCCCCCCCC | 59.21 | 21890473 | |
30 | Ubiquitination | ADASGTEKAFEPATG CCCCCCCCCCCCCCC | 59.21 | 21890473 | |
31 | Ubiquitination | DASGTEKAFEPATGR CCCCCCCCCCCCCCC | 14.06 | 24816145 | |
33 | Phosphorylation | SGTEKAFEPATGRVI CCCCCCCCCCCCCEE | 38.60 | 20068231 | |
42 | Phosphorylation | ATGRVIATFTCSGEK CCCCEEEEEEECCCE | 14.35 | 26437602 | |
44 | Phosphorylation | GRVIATFTCSGEKEV CCEEEEEEECCCEEH | 11.04 | 21406692 | |
45 | Glutathionylation | RVIATFTCSGEKEVN CEEEEEEECCCEEHH | 4.26 | 22555962 | |
46 | Phosphorylation | VIATFTCSGEKEVNL EEEEEEECCCEEHHH | 47.10 | 21406692 | |
49 | Acetylation | TFTCSGEKEVNLAVQ EEEECCCEEHHHHHH | 71.18 | 26051181 | |
49 | Ubiquitination | TFTCSGEKEVNLAVQ EEEECCCEEHHHHHH | 71.18 | - | |
54 | Ubiquitination | GEKEVNLAVQNAKAA CCEEHHHHHHHHHHH | 8.81 | 21890473 | |
54 | Ubiquitination | GEKEVNLAVQNAKAA CCEEHHHHHHHHHHH | 8.81 | 21890473 | |
54 | Ubiquitination | GEKEVNLAVQNAKAA CCEEHHHHHHHHHHH | 8.81 | 27667366 | |
59 | Acetylation | NLAVQNAKAAFKIWS HHHHHHHHHHHHHHH | 48.04 | 27452117 | |
59 | Succinylation | NLAVQNAKAAFKIWS HHHHHHHHHHHHHHH | 48.04 | - | |
59 | Succinylation | NLAVQNAKAAFKIWS HHHHHHHHHHHHHHH | 48.04 | - | |
59 | Ubiquitination | NLAVQNAKAAFKIWS HHHHHHHHHHHHHHH | 48.04 | - | |
63 | Acetylation | QNAKAAFKIWSQKSG HHHHHHHHHHHCCCH | 38.24 | 25953088 | |
66 | Phosphorylation | KAAFKIWSQKSGMER HHHHHHHHCCCHHHH | 31.07 | 30576142 | |
68 | Acetylation | AFKIWSQKSGMERCR HHHHHHCCCHHHHHH | 43.38 | 25953088 | |
68 | Ubiquitination | AFKIWSQKSGMERCR HHHHHHCCCHHHHHH | 43.38 | 21890473 | |
83 | Ubiquitination | ILLEAARIIREREDE HHHHHHHHHHHCCCC | 2.74 | 29967540 | |
87 | Ubiquitination | AARIIREREDEIATM HHHHHHHCCCCCEEE | 46.98 | 23000965 | |
92 | Ubiquitination | REREDEIATMECINN HHCCCCCEEEEEHHC | 9.99 | - | |
92 | Neddylation | REREDEIATMECINN HHCCCCCEEEEEHHC | 9.99 | 32015554 | |
92 | Ubiquitination | REREDEIATMECINN HHCCCCCEEEEEHHC | 9.99 | 23000965 | |
93 | Phosphorylation | EREDEIATMECINNG HCCCCCEEEEEHHCC | 21.11 | 24114839 | |
94 | Sulfoxidation | REDEIATMECINNGK CCCCCEEEEEHHCCC | 2.67 | 30846556 | |
101 | Acetylation | MECINNGKSIFEARL EEEHHCCCCCEEEEE | 42.37 | 26051181 | |
113 | Phosphorylation | ARLDIDISWQCLEYY EEECCCCCHHHHHHH | 13.82 | 23663014 | |
119 | Phosphorylation | ISWQCLEYYAGLAAS CCHHHHHHHHHHHHH | 5.90 | 23663014 | |
120 | Phosphorylation | SWQCLEYYAGLAASM CHHHHHHHHHHHHHH | 5.70 | 23663014 | |
125 | Ubiquitination | EYYAGLAASMAGEHI HHHHHHHHHHCCCCC | 12.60 | 24816145 | |
126 | Phosphorylation | YYAGLAASMAGEHIQ HHHHHHHHHCCCCCC | 11.98 | 23663014 | |
138 | Phosphorylation | HIQLPGGSFGYTRRE CCCCCCCCCCCCCCC | 22.78 | 23663014 | |
141 | Phosphorylation | LPGGSFGYTRREPLG CCCCCCCCCCCCCCC | 8.61 | 23663014 | |
142 | Phosphorylation | PGGSFGYTRREPLGV CCCCCCCCCCCCCCE | 24.51 | 23663014 | |
164 | Phosphorylation | NYPFQIASWKSAPAL CCCEEEECCCCCCEE | 36.34 | 24719451 | |
169 | Ubiquitination | IASWKSAPALACGNA EECCCCCCEEECCCE | 34.59 | - | |
176 | Ubiquitination | PALACGNAMVFKPSP CEEECCCEEEECCCC | 4.84 | - | |
179 | Ubiquitination | ACGNAMVFKPSPFTP ECCCEEEECCCCCCC | 6.55 | - | |
228 | Ubiquitination | QHPDVAKVSFTGSVP CCCCEEEEEEECCCC | 4.03 | - | |
228 | Ubiquitination | QHPDVAKVSFTGSVP CCCCEEEEEEECCCC | 4.03 | 23000965 | |
229 | Phosphorylation | HPDVAKVSFTGSVPT CCCEEEEEEECCCCC | 19.18 | 20068231 | |
231 | Phosphorylation | DVAKVSFTGSVPTGM CEEEEEEECCCCCCC | 22.50 | 28857561 | |
233 | Acetylation | AKVSFTGSVPTGMKI EEEEEECCCCCCCCC | 23.13 | - | |
233 | Ubiquitination | AKVSFTGSVPTGMKI EEEEEECCCCCCCCC | 23.13 | - | |
233 | Phosphorylation | AKVSFTGSVPTGMKI EEEEEECCCCCCCCC | 23.13 | 20068231 | |
233 | Ubiquitination | AKVSFTGSVPTGMKI EEEEEECCCCCCCCC | 23.13 | 21890473 | |
236 | Phosphorylation | SFTGSVPTGMKIMEM EEECCCCCCCCCEEE | 47.99 | 26437602 | |
238 | Sulfoxidation | TGSVPTGMKIMEMSA ECCCCCCCCCEEECC | 2.68 | 21406390 | |
239 | Acetylation | GSVPTGMKIMEMSAK CCCCCCCCCEEECCC | 40.00 | 25038526 | |
239 | Ubiquitination | GSVPTGMKIMEMSAK CCCCCCCCCEEECCC | 40.00 | - | |
240 | Acetylation | SVPTGMKIMEMSAKG CCCCCCCCEEECCCC | 1.78 | - | |
240 | Ubiquitination | SVPTGMKIMEMSAKG CCCCCCCCEEECCCC | 1.78 | - | |
240 | Ubiquitination | SVPTGMKIMEMSAKG CCCCCCCCEEECCCC | 1.78 | 22817900 | |
246 | Ubiquitination | KIMEMSAKGIKPVTL CCEEECCCCCCCEEE | 54.59 | - | |
246 | Acetylation | KIMEMSAKGIKPVTL CCEEECCCCCCCEEE | 54.59 | 26051181 | |
246 | Ubiquitination | KIMEMSAKGIKPVTL CCEEECCCCCCCEEE | 54.59 | 30230243 | |
249 | Ubiquitination | EMSAKGIKPVTLELG EECCCCCCCEEEECC | 41.95 | - | |
253 | Phosphorylation | KGIKPVTLELGGKSP CCCCCEEEECCCCCC | 5.35 | 20068231 | |
257 | Phosphorylation | PVTLELGGKSPLIIF CEEEECCCCCCEEEE | 39.63 | 24719451 | |
263 | Ubiquitination | GGKSPLIIFSDCDMN CCCCCEEEEECCCCC | 3.40 | 29967540 | |
267 | Glutathionylation | PLIIFSDCDMNNAVK CEEEEECCCCCHHHH | 5.32 | 22555962 | |
269 | Sulfoxidation | IIFSDCDMNNAVKGA EEEECCCCCHHHHHH | 5.39 | 30846556 | |
270 | Ubiquitination | IFSDCDMNNAVKGAL EEECCCCCHHHHHHH | 21.76 | 29967540 | |
273 | Ubiquitination | DCDMNNAVKGALMAN CCCCCHHHHHHHHHH | 6.80 | 29967540 | |
274 | Acetylation | CDMNNAVKGALMANF CCCCHHHHHHHHHHC | 35.74 | - | |
274 | Ubiquitination | CDMNNAVKGALMANF CCCCHHHHHHHHHHC | 35.74 | - | |
274 | Ubiquitination | CDMNNAVKGALMANF CCCCHHHHHHHHHHC | 35.74 | 20639865 | |
277 | Ubiquitination | NNAVKGALMANFLTQ CHHHHHHHHHHCCCC | 4.55 | 20639865 | |
282 | Ubiquitination | GALMANFLTQGQVCC HHHHHHCCCCCCCCC | 3.33 | 29967540 | |
298 | Acetylation | GTRVFVQKEILDKFT CEEEEEEHHHHHHHH | 41.23 | 19608861 | |
298 | Ubiquitination | GTRVFVQKEILDKFT CEEEEEEHHHHHHHH | 41.23 | 27667366 | |
303 | Acetylation | VQKEILDKFTEEVVK EEHHHHHHHHHHHHH | 51.22 | 23954790 | |
303 | Succinylation | VQKEILDKFTEEVVK EEHHHHHHHHHHHHH | 51.22 | - | |
303 | Succinylation | VQKEILDKFTEEVVK EEHHHHHHHHHHHHH | 51.22 | 21890473 | |
303 | Ubiquitination | VQKEILDKFTEEVVK EEHHHHHHHHHHHHH | 51.22 | 21890473 | |
310 | Acetylation | KFTEEVVKQTQRIKI HHHHHHHHHHCCCCC | 53.45 | 25038526 | |
310 | Malonylation | KFTEEVVKQTQRIKI HHHHHHHHHHCCCCC | 53.45 | 26320211 | |
310 | Ubiquitination | KFTEEVVKQTQRIKI HHHHHHHHHHCCCCC | 53.45 | - | |
316 | Malonylation | VKQTQRIKIGDPLLE HHHHCCCCCCCCCCC | 42.71 | 26320211 | |
316 | Ubiquitination | VKQTQRIKIGDPLLE HHHHCCCCCCCCCCC | 42.71 | - | |
322 | Acetylation | IKIGDPLLEDTRMGP CCCCCCCCCCCCCCC | 7.33 | 19608861 | |
322 | Ubiquitination | IKIGDPLLEDTRMGP CCCCCCCCCCCCCCC | 7.33 | 23000965 | |
327 | Ubiquitination | PLLEDTRMGPLINRP CCCCCCCCCCCCCCH | 7.62 | 21890473 | |
327 | Ubiquitination | PLLEDTRMGPLINRP CCCCCCCCCCCCCCH | 7.62 | 21890473 | |
327 | Ubiquitination | PLLEDTRMGPLINRP CCCCCCCCCCCCCCH | 7.62 | 21890473 | |
334 | Ubiquitination | MGPLINRPHLERVLG CCCCCCCHHHHHHHH | 31.74 | 22817900 | |
340 | Ubiquitination | RPHLERVLGFVKVAK CHHHHHHHHHHHHHH | 5.73 | 30230243 | |
344 | Acetylation | ERVLGFVKVAKEQGA HHHHHHHHHHHHCCC | 33.93 | 23236377 | |
344 | Ubiquitination | ERVLGFVKVAKEQGA HHHHHHHHHHHHCCC | 33.93 | 20639865 | |
347 | Ubiquitination | LGFVKVAKEQGAKVL HHHHHHHHHCCCEEE | 54.26 | 2063986 | |
352 | Acetylation | VAKEQGAKVLCGGDI HHHHCCCEEEECCCE | 42.43 | 26051181 | |
355 | Glutathionylation | EQGAKVLCGGDIYVP HCCCEEEECCCEECC | 6.83 | 22555962 | |
360 | Phosphorylation | VLCGGDIYVPEDPKL EEECCCEECCCCCCC | 18.07 | 7442915 | |
366 | Acetylation | IYVPEDPKLKDGYYM EECCCCCCCCCCEEE | 79.20 | 26051181 | |
368 | Ubiquitination | VPEDPKLKDGYYMRP CCCCCCCCCCEEECC | 56.06 | 20639865 | |
371 | Ubiquitination | DPKLKDGYYMRPCVL CCCCCCCEEECCEEE | 12.29 | 20639865 | |
376 | Ubiquitination | DGYYMRPCVLTNCRD CCEEECCEEEECCCC | 2.50 | 29967540 | |
390 | Ubiquitination | DDMTCVKEEIFGPVM CCCHHHHHHHHHCCE | 35.61 | 29967540 | |
392 | Ubiquitination | MTCVKEEIFGPVMSI CHHHHHHHHHCCEEE | 5.19 | 27667366 | |
416 | Phosphorylation | LERANDTTFGLAAGV HHHCCCCCCCCEEEE | 20.69 | 24076635 | |
442 | Phosphorylation | VAELQAGTCFINNYN HHHHHCCCEEEECCC | 13.78 | 22468782 | |
451 | Phosphorylation | FINNYNVSPVELPFG EEECCCCCCEECCCC | 21.42 | 22468782 | |
460 | Phosphorylation | VELPFGGYKKSGFGR EECCCCCCCCCCCCC | 18.67 | 22468782 | |
461 | Acetylation | ELPFGGYKKSGFGRE ECCCCCCCCCCCCCC | 43.68 | 155651 | |
462 | Acetylation | LPFGGYKKSGFGREN CCCCCCCCCCCCCCC | 47.53 | 24430995 | |
473 | Phosphorylation | GRENGRVTIEYYSQL CCCCCEEEEEEECCC | 13.51 | 26356563 | |
476 | Phosphorylation | NGRVTIEYYSQLKTV CCEEEEEEECCCCEE | 12.45 | 28102081 | |
477 | Phosphorylation | GRVTIEYYSQLKTVC CEEEEEEECCCCEEE | 4.16 | 28152594 | |
478 | Phosphorylation | RVTIEYYSQLKTVCV EEEEEEECCCCEEEE | 28.30 | 28152594 | |
482 | Phosphorylation | EYYSQLKTVCVEMGD EEECCCCEEEEECCC | 27.94 | 29083192 | |
484 | Glutathionylation | YSQLKTVCVEMGDVE ECCCCEEEEECCCHH | 2.31 | 22555962 | |
487 | Sulfoxidation | LKTVCVEMGDVESAF CCEEEEECCCHHHCC | 2.50 | 30846556 | |
492 | Phosphorylation | VEMGDVESAF----- EECCCHHHCC----- | 34.52 | 29083192 | |
497 | Phosphorylation | VESAF---------- HHHCC---------- | 20068231 | ||
500 | Phosphorylation | AF------------- CC------------- | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AL9A1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AL9A1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AL9A1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
THIC_HUMAN | ACAT2 | physical | 22863883 | |
CPIN1_HUMAN | CIAPIN1 | physical | 22863883 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-298, AND MASS SPECTROMETRY. |